CN106474119A - 一种治疗脊髓损伤肌肉萎缩的药物及其使用方法 - Google Patents
一种治疗脊髓损伤肌肉萎缩的药物及其使用方法 Download PDFInfo
- Publication number
- CN106474119A CN106474119A CN201611117196.8A CN201611117196A CN106474119A CN 106474119 A CN106474119 A CN 106474119A CN 201611117196 A CN201611117196 A CN 201611117196A CN 106474119 A CN106474119 A CN 106474119A
- Authority
- CN
- China
- Prior art keywords
- spinal cord
- cord injury
- losartan
- group
- akt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611117196.8A CN106474119A (zh) | 2016-12-07 | 2016-12-07 | 一种治疗脊髓损伤肌肉萎缩的药物及其使用方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611117196.8A CN106474119A (zh) | 2016-12-07 | 2016-12-07 | 一种治疗脊髓损伤肌肉萎缩的药物及其使用方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106474119A true CN106474119A (zh) | 2017-03-08 |
Family
ID=58274996
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611117196.8A Pending CN106474119A (zh) | 2016-12-07 | 2016-12-07 | 一种治疗脊髓损伤肌肉萎缩的药物及其使用方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106474119A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108374041A (zh) * | 2018-03-30 | 2018-08-07 | 南京艾迪康医学检验所有限公司 | 用于fbxo32基因启动子甲基化检测的引物、检测方法及其应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060135422A1 (en) * | 2003-04-17 | 2006-06-22 | Moskowitz David W | Use of angiotensin receptor blockers (ARBs) to treat diseases associated with excess ACE |
CN102946896A (zh) * | 2010-04-30 | 2013-02-27 | 西安大略大学 | Sox9抑制剂 |
CN103479612A (zh) * | 2013-08-27 | 2014-01-01 | 冯世庆 | 奈莫司他的制药用途 |
-
2016
- 2016-12-07 CN CN201611117196.8A patent/CN106474119A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060135422A1 (en) * | 2003-04-17 | 2006-06-22 | Moskowitz David W | Use of angiotensin receptor blockers (ARBs) to treat diseases associated with excess ACE |
CN102946896A (zh) * | 2010-04-30 | 2013-02-27 | 西安大略大学 | Sox9抑制剂 |
CN103479612A (zh) * | 2013-08-27 | 2014-01-01 | 冯世庆 | 奈莫司他的制药用途 |
Non-Patent Citations (2)
Title |
---|
JAN T. GROOTHUIS等: "Angiotensin II contributes to the increased baseline leg vascular resistance in spinal cord-injured individuals", 《JOURNAL OF HYPERTENSION》 * |
王 乐等: "失神经骨骼肌萎缩与氯沙坦通过核因子κB/MuRF1通路的延缓作用", 《中国组织工程研究与临床康复》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108374041A (zh) * | 2018-03-30 | 2018-08-07 | 南京艾迪康医学检验所有限公司 | 用于fbxo32基因启动子甲基化检测的引物、检测方法及其应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Chen et al. | Inhibition of Nrf2/HO-1 signaling leads to increased activation of the NLRP3 inflammasome in osteoarthritis | |
Abate et al. | Cigarette smoking and musculoskeletal disorders | |
Fu et al. | Effect of 1, 25-dihydroxy vitamin D3 on fracture healing and bone remodeling in ovariectomized rat femora | |
Emami et al. | Age dependence of systemic bone loss and recovery following femur fracture in mice | |
Zhou et al. | Expression of proinflammatory cytokines and growth factors at the injured growth plate cartilage in young rats | |
Wang et al. | Impaired glutamatergic projection from the motor cortex to the subthalamic nucleus in 6-hydroxydopamine-lesioned hemi-parkinsonian rats | |
Iqbal et al. | Icariin: a potential compound for the recovery of tibial dyschondroplasia affected chicken via up-regulating BMP-2 expression | |
Wu et al. | Secondary osteoporosis in collagen-induced arthritis rats | |
Li et al. | Verification of pain-related neuromodulation mechanisms of icariin in knee osteoarthritis | |
Harlow et al. | Daily parathyroid hormone administration enhances bone turnover and preserves bone structure after severe immobilization‐induced bone loss | |
Baumann et al. | Deletion of nicotinic acetylcholine receptor alpha9 in mice resulted in altered bone structure | |
Azuma et al. | Effects of active mastication on chronic stress-induced bone loss in mice | |
CN106474119A (zh) | 一种治疗脊髓损伤肌肉萎缩的药物及其使用方法 | |
Malik et al. | Combined virgin coconut oil and tocotrienol-rich fraction protects against bone loss in osteoporotic rat model | |
Corciulo et al. | Physiological levels of estradiol limit murine osteoarthritis progression | |
Wahl et al. | Direct bone formation during distraction osteogenesis does not require TNFα receptors and elevated serum TNFα fails to inhibit bone formation in TNFR1 deficient mice | |
Wahl et al. | Distraction osteogenesis in TNF receptor 1 deficient mice is protected from chronic ethanol exposure | |
CN103945854B (zh) | 从山药分离出的新颖生物活性蛋白及其用途 | |
Pan et al. | Methods for the reliable induction of heterotopic ossification in the conditional Alk2Q207D mouse | |
CN109125331A (zh) | Gabab受体拮抗剂在阻断trek-1通道方面的应用 | |
CN105457028A (zh) | 在骨形成中发挥调控作用的应力敏感性microRNA | |
Hartwich et al. | Rapamycin increases neuroblastoma xenograft and host stromal derived osteoprotegerin inhibiting osteolytic bone disease in a bone metastasis model | |
Ridgley et al. | The physiological effects of IGF-1 (class 1: Ea transgene) over-expression on exercise-induced damage and adaptation in dystrophic muscles of mdx mice | |
Li | Adaptation of Maternal Skeletal Mechano-Responsiveness, Osteocyte Microenvironment, and Bone Marrow Adipocytes in Response to Reproduction and Lactation | |
Zhou et al. | Exercise promotes osteogenic differentiation by activating the long non-coding RNA H19/microRNA-149 axis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20180130 Address after: 300457 Tianjin Binhai New Area Tianjin economic and Technological Development Zone Dongting Road No. 220 Tianjin international biology and Medicine Institute experimental building ten layer S1006-1 and S1006-2 Applicant after: Tianjin Xiaoxi Bio Medical Science & Technology Co., Ltd. Applicant after: Feng Shiqing Address before: 300052 Anshan Road, Heping District, Tianjin, No. 154 (General Hospital Affiliated to Tianjin Medical University) Applicant before: Feng Shiqing |
|
TA01 | Transfer of patent application right | ||
CB02 | Change of applicant information |
Address after: 300 457 days. S1006-1 and S1006-2 on the tenth floor of the experimental building of Tianjin International Biomedical Research Institute, 220 Dongting Road, Tianjin Economic and Technological Development Zone, Binhai New Area, Tianjin Applicant after: Tianjin Yunsanze Biomedical Technology Co., Ltd. Applicant after: Feng Shiqing Address before: 300 457 days. S1006-1 and S1006-2 on the tenth floor of the experimental building of Tianjin International Biomedical Research Institute, 220 Dongting Road, Tianjin Economic and Technological Development Zone, Binhai New Area, Tianjin Applicant before: Tianjin Xiaoxi Bio Medical Science & Technology Co., Ltd. Applicant before: Feng Shiqing |
|
CB02 | Change of applicant information | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170308 |
|
RJ01 | Rejection of invention patent application after publication |